<i>In vitro</i> evidence of oncofetal antigen and TLR-9 agonist co-delivery by alginate nanovaccines for liver cancer immunotherapy

Mengyue Pei, Huiyang Li, Yingwei Zhu, Jian Lü, Chuangnian Zhang

Biomaterials Science · 2022 · 14 citations · 25 references

Concepts

Abstract

histocompatibility showed that APPC was non-toxic within the tested concentration. This study demonstrates that the peptide antigen and the CpG adjuvant co-delivery nanovaccine have potential applications in liver cancer immunotherapy.

References

25